← Weekly analysesHome
mttssn research · Nordic Deep Dive
Schouw & Co. (SCHO.CO)
Industri · Industrikonglomerat (Schouw & Co) · LTM Q1 2026
Analysis date: 2026-06-04
Price at analysis: DKK 643.00
Method: mttssn_streamlined_v1
Conviction: MEDIUM
HOLD
Conviction: MEDIUM
A Danish industrial conglomerate whose blended returns are low (ROIC 5%, EP −DKK 482M), but whose value sits in the portfolio — chiefly BioMar (aquaculture feed). The operating reverse-DCF understates a sum-of-the-parts story; a conglomerate discount applies. HOLD.
Adj. ROIC
5.0%
WACC 8% → spread -3.0pp
Economic Profit
DKK -496M
−DKK 482M (blended; capital-intensive units drag)
FCF Yield
11.2%
11.5% FCF yield
Price / Target
DKK 643 → DKK 650
+1% base; HOLD
Revenue (LTM)
DKK 33.9B
LTM; BioMar-led portfolio
EBIT Margin
4.3%
GAAP; blended low
EV / IC
1.15×
Enterprise value / invested capital
Net Debt
DKK 4.7B
DKK 4.4B
Thesis

Schouw & Co is a Danish industrial holding company with five businesses — BioMar (aquaculture feed, the largest), GPV (electronics manufacturing services), HydraSpecma, Borg Automotive and Fibertex. Blended adjusted ROIC of 5% and −DKK 482M economic profit reflect a mix of capital-intensive, lower-return businesses net of the crown-jewel BioMar.

As a conglomerate, the operating reverse-DCF (−79%) understates a sum-of-the-parts picture: BioMar is a global aquaculture-feed leader with real franchise value, while the other units are more cyclical/lower-return. The relevant frame is SOTP less a conglomerate discount, not a blended NOPAT perpetuity.

Valuation · reverse-DCF & scenarios

The blended reverse-DCF mis-frames a conglomerate; the value is the portfolio — BioMar at a feed-industry multiple plus the cyclical units, less a holding-company discount. Blended ROIC of 5% signals capital-intensity (GPV/HydraSpecma) dragging the average.

Base DKK 650 (−2%) holding the conglomerate discount; bull DKK 800 (BioMar margin recovery + portfolio value crystallisation); bear DKK 500 (cyclical-unit weakness or a wider discount).

Market-implied growth
≥-50.0%
model ceiling — EV implies more than constant-ROIC sustains
No-growth value / share
DKK 180
28% of price; rest = priced-in growth
ROIC − WACC
-3.0 pp
ROIC 5.0% vs WACC 8.0% — positive = value creation
CAP (priced-in)
n/a
years of excess returns the price implies (fades to WACC)

At today’s enterprise value the constant-ROIC reverse-DCF maxes out: even at its sustainable-growth ceiling (~-50.0%, limited by ROIC 5% ≈ WACC 8%) it cannot reach the current EV. No-growth value is DKK 180/share (28% of price); the market prices in growth and/or a higher ROIC than booked — richly valued on this lens. Read the sensitivity grid.

Scenario24m targetImpl. gUpsideProb.Driver
BullDKK 800≥-50%+24%30%BioMar margin recovery + portfolio crystallisation
BaseDKK 650≥-50%+1%45%SOTP; conglomerate discount holds
BearDKK 500≥-50%-22%25%Cyclical-unit weakness or wider discount
Prob-weightedDKK 658+2%100%Scenario-weighted expected value

Sensitivity — fair value / share at WACC × growth

WACC \ g0%3%5%8%10%15%
6.50%29926824219515634
7.25%23019115910155-88
8.00% (base)1801359934-17-173
8.75%1419253-16-70-235
9.50%1115918-55-111-282

Green = fair value above the current price of DKK 643.00. The reverse-DCF conclusion is dominated by WACC and growth — see the whole surface, not a single fair value.

Method & data. NOPAT DKK 843, invested capital and ROIC 5.0% are observed (adjustments.json); WACC 8.0% and terminal g 2.5% are assumptions. EV→equity uses net debt DKK 4,670. The model holds ROIC constant (no fade) over the explicit horizon; the CAP figure instead fades excess returns to WACC.

⤓ Download the full model (.xlsx) — formula-driven sheets; flex the blue input cells and the model cascades in Excel.

Key drivers

1. BioMar crown jewel

A global aquaculture-feed leader — the principal value within the portfolio.

2. Portfolio diversification

Five distinct businesses diversify end-market exposure.

3. Active ownership

A holding-company model with capital-allocation flexibility across units.

4. Cash generation

An 11.5% free-cash yield supports dividends and reinvestment.

5. Value-crystallisation optionality

Portfolio moves could narrow the conglomerate discount.

Key risks
Conclusion

Schouw & Co is a conglomerate whose value lies in BioMar and the portfolio rather than its low blended returns; the operating reverse-DCF understates it. HOLD, medium conviction; base target DKK 650 (−2%).

BioMar margin recovery or portfolio value-crystallisation is the upside; low blended returns and the conglomerate discount are the cautions.